ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

YARW vs UPB // ENTERPRISE SCALE & MARKET CAP

Yarrow Bioscience Inc. (NASDAQ) VS. Upstream Bio Inc. (NASDAQ) • 15-METRIC TALLY: YARW 1 — UPB 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: UPB
market-cap
$183.5M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (YARW VS. UPB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC YARW UPB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -17.80% — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 13.80% 20.40% -6.60 UPB /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 9.31 6.01 +3.30 YARW /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 33.7 39.5 -5.80 UPB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $166.8M $183.5M -$16.7M UPB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR YARW REV UPB REV YARW GROSS % UPB GROSS % YARW FCF UPB FCF
FY 2025 $570.0K $2.9M — — -$33.1M -$133.4M
FY 2024 $501.0K $2.4M — — -$34.0M -$59.7M
FY 2023 $424.0K $2.4M — — -$25.3M -$37.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
YARW // BETA —
UPB // BETA —